COsegregation of VARiants in Panel of Genes

Study of Family COsegregation of Nucleotide VARiants in the Panel of Genes to Validate Their Use in Genetic Counseling

About This Trial

  • This study looks at how specific, uncertain gene changes run in families to better understand hereditary cancer risks.
  • It is open to adults who had genetic testing showing a particular gene change of interest, as well as their adult relatives with or without cancer.
  • Rather than testing a new medication, researchers will examine genetic information across family members to clarify whether a specific gene change increases the risk of cancer.
  • The goal is to provide clearer genetic counseling and help doctors recommend the most effective cancer screening and preventive care options for you and your family.

More Information

  • The aim of the COVAR project is to achieve reliable classification of as many variants of interest as possible from the French OncoGenetics Database (FrOG, https://frog-db.fr/) in order to use them for the genetic counseling.
  • The results obtained through this study will have a major impact on clinical management of the patients and their families conducting in some cases to propose a prophylactic surgery.

Who Can Enroll

  • Age Range: 18 years and older
  • Gender: All
  • Who This Trial is For: This study looks at how specific, uncertain gene changes run in families to better understand hereditary cancer risks.

Study Details

  • Start Date: July 2, 2012
  • Lead Sponsor: Institut Curie
Full Eligibility Criteria

Inclusion Criteria

Index cases:

  • A person carrying a variant of interest in a gene analyzed in a diagnostic setting by one of the laboratories within the Genetics and Cancer Group (GGC)-Unicancer network, classified as class 3, 4 or hypomorphic class 5, and selected by the national expert group for the gene concerned.
  • Age ≥ 18 years.
  • Signed written inform consent "index case" Related parties:
  • Any relative of an index case with cancer
  • Any relative without cancer related to an index case, selected by the investigators, according to family structure and degree of related compared to the index case
  • For class 4 and hypomorphic class 5 variants; relatives currently undergoing analysis or having already obtained a test result for the variant of interest as part of clinical care.
  • Age ≥ 18 years
  • Information and signature of the informed consent "selected relatives"

Exclusion Criteria

  • Minors
  • Persons deprived of liberty or under guardianship (including curators).
  • Absence of signed written inform consent

Treatments

  • Genetic: salivary kit
View Trial Locations and Contact Information (opens in new tab)